Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cognetivity Neurosciences Ltd C.CGN

Alternate Symbol(s):  CGNSF

Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help... see more

Recent & Breaking News (CSE:CGN)

Canadian Investment Regulatory Organization Trading Halt - CGN

Canada NewsWire June 6, 2024

CognICA(TM) Shown to Save Tens of Millions of Dollars in Healthcare Costs Annually and Improve Patient Outcomes in the UK National Health Service

Newsfile October 24, 2023

Cognetivity Neurosciences, UC Health collaborate to detect cognitive impairment

Jocelyn Aspa October 11, 2023

Cognetivity Neurosciences and UC Health Partner to Improve Early Detection of Cognitive Impairment in USA

Newsfile October 11, 2023

Cognetivity Neurosciences Announces Commercial Agreement with Mediclinic to Provide Cognitive Assessment to Over 50s

Newsfile October 3, 2023

Cognetivity Neurosciences Partners with No Fear Counselling to Pioneer Brain Health Assessment Through Groundbreaking AI Technology

Newsfile September 21, 2023

Cognetivity Neurosciences' AI Powered CognICA Platform Wins Major Industry Award

Newsfile September 13, 2023

Cognetivity Neurosciences' AI Powered CognICA Platform Shortlisted for Major Industry Award

Newsfile September 5, 2023

Cognetivity Neurosciences Announces Publication of Peer-Reviewed Article Showing Effectiveness of its AI Powered CognICA Technology in Detecting Early-Stage Alzheimer's Disease

Newsfile August 30, 2023

Cognetivity Neurosciences Announces Successful Registration With Health Canada for Clinical use of CognICA(TM) AI-Powered Brain Health Technology in Canada

Newsfile August 2, 2023

Healthcare companies hail FDA's approval of new Alzheimer’s drug

Jonathon Brown July 7, 2023

New Disease Modifying Drug for Alzheimer's Disease Fully Approved by FDA, Highlighting the Crucial Role for Cognetivity in Early Detection and Monitoring

Newsfile July 7, 2023

Cognetivity Neurosciences Partners with Clairvo to Advance AI Powered Brain Health Management in Japan

Newsfile June 13, 2023

Cognetivity Neurosciences AI Platform Technology to Play a Pivotal Role in the Effective Delivery of Newly Approved Alzheimer's Drugs

Newsfile June 6, 2023

Cognetivity Neurosciences Announces Collaboration with Alzheimer's Society to Further Expand its AI Algorithms

Newsfile May 31, 2023

Cognetivity Neurosciences (CSE:CGN), a game-changer for early Alzheimer’s detection?

Jonathon Brown May 10, 2023

Eli Lilly Releases Positive Results on Latest Disease Modifying Therapeutic for Alzheimer's Disease, Highlighting Need for Cognetivity's CognICA Platform

Newsfile May 9, 2023

Cognetivity Neurosciences Announces Agreement with Mitsui Sumitomo Aioi Life Insurance of Japan to Provide CognICA Technology to Customers

Newsfile April 25, 2023

Cognetivity Neurosciences Appoints Renowned Life Sciences Leader Karimah Es Sabar as Director

Newsfile April 20, 2023

Cognetivity Neurosciences Unveils Groundbreaking Research on Cognition and Sleep, Extends Collaboration with University of Oxford

Newsfile March 23, 2023